nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—CHRM3—epilepsy syndrome	0.212	0.3	CbGaD
Aclidinium—CHRM1—epilepsy syndrome	0.197	0.28	CbGaD
Aclidinium—CHRM2—epilepsy syndrome	0.161	0.229	CbGaD
Aclidinium—BCHE—epilepsy syndrome	0.134	0.191	CbGaD
Aclidinium—Tiotropium—CHRM3—epilepsy syndrome	0.000799	0.126	CrCbGaD
Aclidinium—Tiotropium—CHRM1—epilepsy syndrome	0.000745	0.118	CrCbGaD
Aclidinium—CHRM4—head—epilepsy syndrome	0.000725	0.0471	CbGeAlD
Aclidinium—CHRM4—nervous system—epilepsy syndrome	0.000687	0.0447	CbGeAlD
Aclidinium—CHRM2—forebrain—epilepsy syndrome	0.000679	0.0441	CbGeAlD
Aclidinium—CHRM4—central nervous system—epilepsy syndrome	0.000662	0.043	CbGeAlD
Aclidinium—CHRM2—telencephalon—epilepsy syndrome	0.000625	0.0406	CbGeAlD
Aclidinium—CHRM1—forebrain—epilepsy syndrome	0.000618	0.0402	CbGeAlD
Aclidinium—Tiotropium—CHRM2—epilepsy syndrome	0.000608	0.0962	CrCbGaD
Aclidinium—CHRM1—telencephalon—epilepsy syndrome	0.000568	0.0369	CbGeAlD
Aclidinium—CHRM5—head—epilepsy syndrome	0.000567	0.0368	CbGeAlD
Aclidinium—Clidinium—CHRM3—epilepsy syndrome	0.000554	0.0876	CrCbGaD
Aclidinium—CHRM3—forebrain—epilepsy syndrome	0.000553	0.036	CbGeAlD
Aclidinium—CHRM5—nervous system—epilepsy syndrome	0.000537	0.0349	CbGeAlD
Aclidinium—Trospium—CHRM3—epilepsy syndrome	0.000533	0.0843	CrCbGaD
Aclidinium—CHRM4—brain—epilepsy syndrome	0.000525	0.0341	CbGeAlD
Aclidinium—CHRM5—central nervous system—epilepsy syndrome	0.000517	0.0336	CbGeAlD
Aclidinium—Clidinium—CHRM1—epilepsy syndrome	0.000516	0.0817	CrCbGaD
Aclidinium—CHRM3—telencephalon—epilepsy syndrome	0.000509	0.0331	CbGeAlD
Aclidinium—Trospium—CHRM1—epilepsy syndrome	0.000497	0.0786	CrCbGaD
Aclidinium—BCHE—brainstem—epilepsy syndrome	0.000468	0.0304	CbGeAlD
Aclidinium—Osteoarthritis—Valproic Acid—epilepsy syndrome	0.000466	0.00306	CcSEcCtD
Aclidinium—Sinusitis—Clonazepam—epilepsy syndrome	0.000463	0.00304	CcSEcCtD
Aclidinium—Infection—Clobazam—epilepsy syndrome	0.000462	0.00304	CcSEcCtD
Aclidinium—Rhinitis—Zonisamide—epilepsy syndrome	0.00046	0.00303	CcSEcCtD
Aclidinium—Eye disorder—Vigabatrin—epilepsy syndrome	0.00046	0.00303	CcSEcCtD
Aclidinium—Sinusitis—Phenytoin—epilepsy syndrome	0.000459	0.00302	CcSEcCtD
Aclidinium—Sinusitis—Oxcarbazepine—epilepsy syndrome	0.000457	0.00301	CcSEcCtD
Aclidinium—Nervous system disorder—Clobazam—epilepsy syndrome	0.000456	0.003	CcSEcCtD
Aclidinium—Urinary tract disorder—Zonisamide—epilepsy syndrome	0.000454	0.00298	CcSEcCtD
Aclidinium—Eye disorder—Diazepam—epilepsy syndrome	0.000453	0.00298	CcSEcCtD
Aclidinium—Infestation NOS—Lamotrigine—epilepsy syndrome	0.000452	0.00297	CcSEcCtD
Aclidinium—Infestation—Lamotrigine—epilepsy syndrome	0.000452	0.00297	CcSEcCtD
Aclidinium—BCHE—forebrain—epilepsy syndrome	0.000452	0.0293	CbGeAlD
Aclidinium—Urethral disorder—Zonisamide—epilepsy syndrome	0.00045	0.00296	CcSEcCtD
Aclidinium—Mepenzolate—CHRM3—epilepsy syndrome	0.000445	0.0704	CrCbGaD
Aclidinium—Diabetes mellitus—Gabapentin—epilepsy syndrome	0.000444	0.00292	CcSEcCtD
Aclidinium—Rhinitis—Clonazepam—epilepsy syndrome	0.000444	0.00292	CcSEcCtD
Aclidinium—Rhinitis—Phenytoin—epilepsy syndrome	0.000441	0.0029	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Rufinamide—epilepsy syndrome	0.00044	0.0029	CcSEcCtD
Aclidinium—Vomiting—Amobarbital—epilepsy syndrome	0.00044	0.0029	CcSEcCtD
Aclidinium—Sinusitis—Carbamazepine—epilepsy syndrome	0.000439	0.00289	CcSEcCtD
Aclidinium—Rhinitis—Oxcarbazepine—epilepsy syndrome	0.000438	0.00288	CcSEcCtD
Aclidinium—Urinary tract disorder—Clonazepam—epilepsy syndrome	0.000437	0.00288	CcSEcCtD
Aclidinium—Vision blurred—Midazolam—epilepsy syndrome	0.000435	0.00286	CcSEcCtD
Aclidinium—Urethral disorder—Clonazepam—epilepsy syndrome	0.000434	0.00285	CcSEcCtD
Aclidinium—Headache—Amobarbital—epilepsy syndrome	0.000434	0.00285	CcSEcCtD
Aclidinium—Cardiac failure—Pregabalin—epilepsy syndrome	0.000432	0.00284	CcSEcCtD
Aclidinium—Vision blurred—Levetiracetam—epilepsy syndrome	0.000429	0.00282	CcSEcCtD
Aclidinium—Eye disorder—Zonisamide—epilepsy syndrome	0.000429	0.00282	CcSEcCtD
Aclidinium—Vomiting—Primidone—epilepsy syndrome	0.000424	0.00279	CcSEcCtD
Aclidinium—Sinusitis—Lamotrigine—epilepsy syndrome	0.000424	0.00279	CcSEcCtD
Aclidinium—Osteoarthritis—Pregabalin—epilepsy syndrome	0.000421	0.00277	CcSEcCtD
Aclidinium—Rhinitis—Carbamazepine—epilepsy syndrome	0.000421	0.00277	CcSEcCtD
Aclidinium—Headache—Primidone—epilepsy syndrome	0.000418	0.00275	CcSEcCtD
Aclidinium—Mepenzolate—CHRM1—epilepsy syndrome	0.000415	0.0657	CrCbGaD
Aclidinium—BCHE—telencephalon—epilepsy syndrome	0.000415	0.027	CbGeAlD
Aclidinium—Urinary tract disorder—Carbamazepine—epilepsy syndrome	0.000414	0.00273	CcSEcCtD
Aclidinium—Mediastinal disorder—Zonisamide—epilepsy syndrome	0.000414	0.00272	CcSEcCtD
Aclidinium—Eye disorder—Clonazepam—epilepsy syndrome	0.000414	0.00272	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Lacosamide—epilepsy syndrome	0.000414	0.00272	CcSEcCtD
Aclidinium—Cough—Propofol—epilepsy syndrome	0.000411	0.00271	CcSEcCtD
Aclidinium—Urethral disorder—Carbamazepine—epilepsy syndrome	0.000411	0.00271	CcSEcCtD
Aclidinium—CHRM5—brain—epilepsy syndrome	0.000411	0.0267	CbGeAlD
Aclidinium—Eye disorder—Oxcarbazepine—epilepsy syndrome	0.000409	0.00269	CcSEcCtD
Aclidinium—Rhinitis—Lamotrigine—epilepsy syndrome	0.000407	0.00267	CcSEcCtD
Aclidinium—Trospium—CHRM2—epilepsy syndrome	0.000406	0.0642	CrCbGaD
Aclidinium—Vision blurred—Vigabatrin—epilepsy syndrome	0.000404	0.00266	CcSEcCtD
Aclidinium—Cough—Midazolam—epilepsy syndrome	0.000403	0.00265	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Clobazam—epilepsy syndrome	0.000401	0.00264	CcSEcCtD
Aclidinium—Urinary retention—Pregabalin—epilepsy syndrome	0.0004	0.00263	CcSEcCtD
Aclidinium—Vision blurred—Diazepam—epilepsy syndrome	0.000398	0.00262	CcSEcCtD
Aclidinium—Cough—Levetiracetam—epilepsy syndrome	0.000398	0.00262	CcSEcCtD
Aclidinium—Cardiac failure—Gabapentin—epilepsy syndrome	0.000396	0.0026	CcSEcCtD
Aclidinium—Dry mouth—Propofol—epilepsy syndrome	0.000393	0.00258	CcSEcCtD
Aclidinium—Eye disorder—Carbamazepine—epilepsy syndrome	0.000392	0.00258	CcSEcCtD
Aclidinium—CHRM2—head—epilepsy syndrome	0.000389	0.0253	CbGeAlD
Aclidinium—Osteoarthritis—Gabapentin—epilepsy syndrome	0.000386	0.00254	CcSEcCtD
Aclidinium—Dry mouth—Midazolam—epilepsy syndrome	0.000384	0.00253	CcSEcCtD
Aclidinium—Cough—Fosphenytoin—epilepsy syndrome	0.000384	0.00252	CcSEcCtD
Aclidinium—Eye disorder—Lamotrigine—epilepsy syndrome	0.000379	0.00249	CcSEcCtD
Aclidinium—Mediastinal disorder—Carbamazepine—epilepsy syndrome	0.000378	0.00249	CcSEcCtD
Aclidinium—Nasopharyngitis—Pregabalin—epilepsy syndrome	0.000377	0.00248	CcSEcCtD
Aclidinium—Tachycardia—Propofol—epilepsy syndrome	0.000376	0.00247	CcSEcCtD
Aclidinium—Cough—Vigabatrin—epilepsy syndrome	0.000374	0.00246	CcSEcCtD
Aclidinium—Diabetes mellitus—Topiramate—epilepsy syndrome	0.000374	0.00246	CcSEcCtD
Aclidinium—Vomiting—Trimethadione—epilepsy syndrome	0.000373	0.00245	CcSEcCtD
Aclidinium—Infection—Levetiracetam—epilepsy syndrome	0.000369	0.00243	CcSEcCtD
Aclidinium—Nervous system disorder—Midazolam—epilepsy syndrome	0.000369	0.00243	CcSEcCtD
Aclidinium—CHRM2—nervous system—epilepsy syndrome	0.000369	0.024	CbGeAlD
Aclidinium—Cough—Diazepam—epilepsy syndrome	0.000368	0.00242	CcSEcCtD
Aclidinium—Headache—Trimethadione—epilepsy syndrome	0.000368	0.00242	CcSEcCtD
Aclidinium—Tachycardia—Midazolam—epilepsy syndrome	0.000367	0.00242	CcSEcCtD
Aclidinium—Urinary retention—Gabapentin—epilepsy syndrome	0.000367	0.00242	CcSEcCtD
Aclidinium—Dry mouth—Fosphenytoin—epilepsy syndrome	0.000366	0.00241	CcSEcCtD
Aclidinium—Mediastinal disorder—Lamotrigine—epilepsy syndrome	0.000366	0.0024	CcSEcCtD
Aclidinium—Nervous system disorder—Levetiracetam—epilepsy syndrome	0.000365	0.0024	CcSEcCtD
Aclidinium—Vision blurred—Clonazepam—epilepsy syndrome	0.000363	0.00239	CcSEcCtD
Aclidinium—Vision blurred—Oxcarbazepine—epilepsy syndrome	0.000359	0.00236	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.000358	0.00235	CcSEcCtD
Aclidinium—Infection—Fosphenytoin—epilepsy syndrome	0.000357	0.00235	CcSEcCtD
Aclidinium—Cough—Felbamate—epilepsy syndrome	0.000356	0.00234	CcSEcCtD
Aclidinium—CHRM2—central nervous system—epilepsy syndrome	0.000355	0.0231	CbGeAlD
Aclidinium—CHRM1—head—epilepsy syndrome	0.000354	0.023	CbGeAlD
Aclidinium—Dry mouth—Diazepam—epilepsy syndrome	0.000351	0.00231	CcSEcCtD
Aclidinium—Tachycardia—Fosphenytoin—epilepsy syndrome	0.00035	0.0023	CcSEcCtD
Aclidinium—Diarrhoea—Rufinamide—epilepsy syndrome	0.000349	0.0023	CcSEcCtD
Aclidinium—Cough—Zonisamide—epilepsy syndrome	0.000349	0.00229	CcSEcCtD
Aclidinium—Infection—Vigabatrin—epilepsy syndrome	0.000348	0.00229	CcSEcCtD
Aclidinium—Nasopharyngitis—Gabapentin—epilepsy syndrome	0.000345	0.00227	CcSEcCtD
Aclidinium—Vision blurred—Carbamazepine—epilepsy syndrome	0.000344	0.00226	CcSEcCtD
Aclidinium—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.000343	0.00226	CcSEcCtD
Aclidinium—Infection—Diazepam—epilepsy syndrome	0.000342	0.00225	CcSEcCtD
Aclidinium—Dry mouth—Felbamate—epilepsy syndrome	0.00034	0.00224	CcSEcCtD
Aclidinium—Mepenzolate—CHRM2—epilepsy syndrome	0.000339	0.0536	CrCbGaD
Aclidinium—Nervous system disorder—Diazepam—epilepsy syndrome	0.000338	0.00222	CcSEcCtD
Aclidinium—Sinusitis—Valproic Acid—epilepsy syndrome	0.000337	0.00222	CcSEcCtD
Aclidinium—Cough—Clonazepam—epilepsy syndrome	0.000336	0.00221	CcSEcCtD
Aclidinium—Tachycardia—Diazepam—epilepsy syndrome	0.000336	0.00221	CcSEcCtD
Aclidinium—CHRM1—nervous system—epilepsy syndrome	0.000336	0.0218	CbGeAlD
Aclidinium—Cough—Phenytoin—epilepsy syndrome	0.000334	0.0022	CcSEcCtD
Aclidinium—Dry mouth—Zonisamide—epilepsy syndrome	0.000333	0.00219	CcSEcCtD
Aclidinium—Vision blurred—Lamotrigine—epilepsy syndrome	0.000333	0.00219	CcSEcCtD
Aclidinium—Cough—Oxcarbazepine—epilepsy syndrome	0.000332	0.00219	CcSEcCtD
Aclidinium—Infection—Felbamate—epilepsy syndrome	0.000331	0.00218	CcSEcCtD
Aclidinium—Vomiting—Phenobarbital—epilepsy syndrome	0.00033	0.00217	CcSEcCtD
Aclidinium—Diarrhoea—Lacosamide—epilepsy syndrome	0.000328	0.00216	CcSEcCtD
Aclidinium—BCHE—medulla oblongata—epilepsy syndrome	0.000326	0.0212	CbGeAlD
Aclidinium—Headache—Phenobarbital—epilepsy syndrome	0.000326	0.00214	CcSEcCtD
Aclidinium—Tachycardia—Felbamate—epilepsy syndrome	0.000325	0.00214	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.000325	0.00214	CcSEcCtD
Aclidinium—Osteoarthritis—Topiramate—epilepsy syndrome	0.000325	0.00214	CcSEcCtD
Aclidinium—Infestation—Pregabalin—epilepsy syndrome	0.000325	0.00214	CcSEcCtD
Aclidinium—Infestation NOS—Pregabalin—epilepsy syndrome	0.000325	0.00214	CcSEcCtD
Aclidinium—Vomiting—Rufinamide—epilepsy syndrome	0.000324	0.00213	CcSEcCtD
Aclidinium—Infection—Zonisamide—epilepsy syndrome	0.000324	0.00213	CcSEcCtD
Aclidinium—CHRM1—central nervous system—epilepsy syndrome	0.000323	0.021	CbGeAlD
Aclidinium—Rhinitis—Valproic Acid—epilepsy syndrome	0.000323	0.00213	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.000321	0.00211	CcSEcCtD
Aclidinium—Dry mouth—Clonazepam—epilepsy syndrome	0.000321	0.00211	CcSEcCtD
Aclidinium—Nervous system disorder—Zonisamide—epilepsy syndrome	0.00032	0.0021	CcSEcCtD
Aclidinium—Headache—Rufinamide—epilepsy syndrome	0.00032	0.0021	CcSEcCtD
Aclidinium—Dry mouth—Phenytoin—epilepsy syndrome	0.000319	0.0021	CcSEcCtD
Aclidinium—Tachycardia—Zonisamide—epilepsy syndrome	0.000318	0.00209	CcSEcCtD
Aclidinium—Urinary tract disorder—Valproic Acid—epilepsy syndrome	0.000318	0.00209	CcSEcCtD
Aclidinium—Diarrhoea—Clobazam—epilepsy syndrome	0.000318	0.00209	CcSEcCtD
Aclidinium—Dry mouth—Oxcarbazepine—epilepsy syndrome	0.000317	0.00209	CcSEcCtD
Aclidinium—CHRM3—head—epilepsy syndrome	0.000317	0.0206	CbGeAlD
Aclidinium—Urethral disorder—Valproic Acid—epilepsy syndrome	0.000316	0.00208	CcSEcCtD
Aclidinium—Infection—Clonazepam—epilepsy syndrome	0.000312	0.00206	CcSEcCtD
Aclidinium—Infection—Phenytoin—epilepsy syndrome	0.00031	0.00204	CcSEcCtD
Aclidinium—Urinary retention—Topiramate—epilepsy syndrome	0.000309	0.00203	CcSEcCtD
Aclidinium—Infection—Oxcarbazepine—epilepsy syndrome	0.000309	0.00203	CcSEcCtD
Aclidinium—Nervous system disorder—Clonazepam—epilepsy syndrome	0.000308	0.00203	CcSEcCtD
Aclidinium—Cough—Lamotrigine—epilepsy syndrome	0.000308	0.00203	CcSEcCtD
Aclidinium—Tachycardia—Clonazepam—epilepsy syndrome	0.000307	0.00202	CcSEcCtD
Aclidinium—Nervous system disorder—Phenytoin—epilepsy syndrome	0.000306	0.00202	CcSEcCtD
Aclidinium—Tachycardia—Phenytoin—epilepsy syndrome	0.000305	0.00201	CcSEcCtD
Aclidinium—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.000305	0.002	CcSEcCtD
Aclidinium—Vomiting—Lacosamide—epilepsy syndrome	0.000305	0.002	CcSEcCtD
Aclidinium—Sinusitis—Pregabalin—epilepsy syndrome	0.000304	0.002	CcSEcCtD
Aclidinium—Dry mouth—Carbamazepine—epilepsy syndrome	0.000304	0.002	CcSEcCtD
Aclidinium—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000303	0.00199	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000302	0.00199	CcSEcCtD
Aclidinium—Eye disorder—Valproic Acid—epilepsy syndrome	0.000301	0.00198	CcSEcCtD
Aclidinium—CHRM3—nervous system—epilepsy syndrome	0.0003	0.0195	CbGeAlD
Aclidinium—Headache—Lacosamide—epilepsy syndrome	0.0003	0.00197	CcSEcCtD
Aclidinium—BCHE—midbrain—epilepsy syndrome	0.000298	0.0194	CbGeAlD
Aclidinium—Infestation—Gabapentin—epilepsy syndrome	0.000298	0.00196	CcSEcCtD
Aclidinium—Infestation NOS—Gabapentin—epilepsy syndrome	0.000298	0.00196	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000297	0.00196	CcSEcCtD
Aclidinium—Infection—Carbamazepine—epilepsy syndrome	0.000296	0.00195	CcSEcCtD
Aclidinium—Vomiting—Clobazam—epilepsy syndrome	0.000296	0.00194	CcSEcCtD
Aclidinium—Dry mouth—Lamotrigine—epilepsy syndrome	0.000294	0.00193	CcSEcCtD
Aclidinium—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000292	0.00192	CcSEcCtD
Aclidinium—Rhinitis—Pregabalin—epilepsy syndrome	0.000292	0.00192	CcSEcCtD
Aclidinium—Headache—Clobazam—epilepsy syndrome	0.000291	0.00192	CcSEcCtD
Aclidinium—Tachycardia—Carbamazepine—epilepsy syndrome	0.000291	0.00191	CcSEcCtD
Aclidinium—BCHE—spinal cord—epilepsy syndrome	0.000291	0.0189	CbGeAlD
Aclidinium—Nasopharyngitis—Topiramate—epilepsy syndrome	0.000291	0.00191	CcSEcCtD
Aclidinium—Mediastinal disorder—Valproic Acid—epilepsy syndrome	0.00029	0.00191	CcSEcCtD
Aclidinium—CHRM3—central nervous system—epilepsy syndrome	0.000289	0.0188	CbGeAlD
Aclidinium—Urinary tract disorder—Pregabalin—epilepsy syndrome	0.000288	0.00189	CcSEcCtD
Aclidinium—Infection—Lamotrigine—epilepsy syndrome	0.000286	0.00188	CcSEcCtD
Aclidinium—Urethral disorder—Pregabalin—epilepsy syndrome	0.000286	0.00188	CcSEcCtD
Aclidinium—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000284	0.00187	CcSEcCtD
Aclidinium—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000283	0.00186	CcSEcCtD
Aclidinium—CHRM2—brain—epilepsy syndrome	0.000282	0.0183	CbGeAlD
Aclidinium—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000282	0.00185	CcSEcCtD
Aclidinium—Tachycardia—Lamotrigine—epilepsy syndrome	0.000281	0.00185	CcSEcCtD
Aclidinium—Sinusitis—Gabapentin—epilepsy syndrome	0.000279	0.00184	CcSEcCtD
Aclidinium—Tiotropium—CYP2D6—epilepsy syndrome	0.000278	0.044	CrCbGaD
Aclidinium—Eye disorder—Pregabalin—epilepsy syndrome	0.000272	0.00179	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000271	0.00179	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.00027	0.00177	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000268	0.00176	CcSEcCtD
Aclidinium—Rhinitis—Gabapentin—epilepsy syndrome	0.000268	0.00176	CcSEcCtD
Aclidinium—Vision blurred—Valproic Acid—epilepsy syndrome	0.000264	0.00174	CcSEcCtD
Aclidinium—Urinary tract disorder—Gabapentin—epilepsy syndrome	0.000264	0.00174	CcSEcCtD
Aclidinium—Vomiting—Acetazolamide—epilepsy syndrome	0.000263	0.00173	CcSEcCtD
Aclidinium—Diarrhoea—Propofol—epilepsy syndrome	0.000263	0.00173	CcSEcCtD
Aclidinium—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000263	0.00173	CcSEcCtD
Aclidinium—Urethral disorder—Gabapentin—epilepsy syndrome	0.000262	0.00172	CcSEcCtD
Aclidinium—Headache—Acetazolamide—epilepsy syndrome	0.00026	0.00171	CcSEcCtD
Aclidinium—BCHE—head—epilepsy syndrome	0.000259	0.0168	CbGeAlD
Aclidinium—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000257	0.00169	CcSEcCtD
Aclidinium—CHRM1—brain—epilepsy syndrome	0.000257	0.0167	CbGeAlD
Aclidinium—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000254	0.00167	CcSEcCtD
Aclidinium—Infestation—Topiramate—epilepsy syndrome	0.00025	0.00165	CcSEcCtD
Aclidinium—Infestation NOS—Topiramate—epilepsy syndrome	0.00025	0.00165	CcSEcCtD
Aclidinium—Eye disorder—Gabapentin—epilepsy syndrome	0.00025	0.00164	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000249	0.00164	CcSEcCtD
Aclidinium—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000246	0.00162	CcSEcCtD
Aclidinium—BCHE—nervous system—epilepsy syndrome	0.000245	0.0159	CbGeAlD
Aclidinium—Cough—Valproic Acid—epilepsy syndrome	0.000245	0.00161	CcSEcCtD
Aclidinium—Vomiting—Propofol—epilepsy syndrome	0.000245	0.00161	CcSEcCtD
Aclidinium—Headache—Propofol—epilepsy syndrome	0.000241	0.00159	CcSEcCtD
Aclidinium—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000241	0.00158	CcSEcCtD
Aclidinium—Vomiting—Midazolam—epilepsy syndrome	0.000239	0.00157	CcSEcCtD
Aclidinium—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000239	0.00157	CcSEcCtD
Aclidinium—Vision blurred—Pregabalin—epilepsy syndrome	0.000239	0.00157	CcSEcCtD
Aclidinium—Vomiting—Levetiracetam—epilepsy syndrome	0.000236	0.00156	CcSEcCtD
Aclidinium—BCHE—central nervous system—epilepsy syndrome	0.000236	0.0153	CbGeAlD
Aclidinium—Headache—Midazolam—epilepsy syndrome	0.000236	0.00155	CcSEcCtD
Aclidinium—Diarrhoea—Diazepam—epilepsy syndrome	0.000236	0.00155	CcSEcCtD
Aclidinium—Sinusitis—Topiramate—epilepsy syndrome	0.000235	0.00155	CcSEcCtD
Aclidinium—Dry mouth—Valproic Acid—epilepsy syndrome	0.000234	0.00154	CcSEcCtD
Aclidinium—Headache—Levetiracetam—epilepsy syndrome	0.000233	0.00153	CcSEcCtD
Aclidinium—BCHE—cerebellum—epilepsy syndrome	0.000231	0.015	CbGeAlD
Aclidinium—CHRM3—brain—epilepsy syndrome	0.00023	0.0149	CbGeAlD
Aclidinium—Vomiting—Fosphenytoin—epilepsy syndrome	0.000228	0.0015	CcSEcCtD
Aclidinium—Diarrhoea—Felbamate—epilepsy syndrome	0.000228	0.0015	CcSEcCtD
Aclidinium—Infection—Valproic Acid—epilepsy syndrome	0.000227	0.0015	CcSEcCtD
Aclidinium—Rhinitis—Topiramate—epilepsy syndrome	0.000225	0.00148	CcSEcCtD
Aclidinium—Headache—Fosphenytoin—epilepsy syndrome	0.000225	0.00148	CcSEcCtD
Aclidinium—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000225	0.00148	CcSEcCtD
Aclidinium—Tachycardia—Valproic Acid—epilepsy syndrome	0.000223	0.00147	CcSEcCtD
Aclidinium—Diarrhoea—Zonisamide—epilepsy syndrome	0.000223	0.00147	CcSEcCtD
Aclidinium—Vomiting—Vigabatrin—epilepsy syndrome	0.000222	0.00146	CcSEcCtD
Aclidinium—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000222	0.00146	CcSEcCtD
Aclidinium—Cough—Pregabalin—epilepsy syndrome	0.000221	0.00146	CcSEcCtD
Aclidinium—Urethral disorder—Topiramate—epilepsy syndrome	0.00022	0.00145	CcSEcCtD
Aclidinium—Vision blurred—Gabapentin—epilepsy syndrome	0.000219	0.00144	CcSEcCtD
Aclidinium—Headache—Vigabatrin—epilepsy syndrome	0.000219	0.00144	CcSEcCtD
Aclidinium—Vomiting—Diazepam—epilepsy syndrome	0.000219	0.00144	CcSEcCtD
Aclidinium—Headache—Diazepam—epilepsy syndrome	0.000216	0.00142	CcSEcCtD
Aclidinium—Diarrhoea—Clonazepam—epilepsy syndrome	0.000215	0.00142	CcSEcCtD
Aclidinium—Diarrhoea—Phenytoin—epilepsy syndrome	0.000214	0.00141	CcSEcCtD
Aclidinium—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000213	0.0014	CcSEcCtD
Aclidinium—Vomiting—Felbamate—epilepsy syndrome	0.000212	0.00139	CcSEcCtD
Aclidinium—Dry mouth—Pregabalin—epilepsy syndrome	0.000211	0.00139	CcSEcCtD
Aclidinium—Eye disorder—Topiramate—epilepsy syndrome	0.00021	0.00138	CcSEcCtD
Aclidinium—Headache—Felbamate—epilepsy syndrome	0.000209	0.00137	CcSEcCtD
Aclidinium—Vomiting—Zonisamide—epilepsy syndrome	0.000207	0.00136	CcSEcCtD
Aclidinium—Infection—Pregabalin—epilepsy syndrome	0.000206	0.00135	CcSEcCtD
Aclidinium—Headache—Zonisamide—epilepsy syndrome	0.000204	0.00134	CcSEcCtD
Aclidinium—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000204	0.00134	CcSEcCtD
Aclidinium—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000203	0.00134	CcSEcCtD
Aclidinium—Cough—Gabapentin—epilepsy syndrome	0.000203	0.00134	CcSEcCtD
Aclidinium—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000203	0.00133	CcSEcCtD
Aclidinium—Tachycardia—Pregabalin—epilepsy syndrome	0.000202	0.00133	CcSEcCtD
Aclidinium—Vomiting—Clonazepam—epilepsy syndrome	0.0002	0.00132	CcSEcCtD
Aclidinium—Vomiting—Phenytoin—epilepsy syndrome	0.000199	0.00131	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000198	0.0013	CcSEcCtD
Aclidinium—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000198	0.0013	CcSEcCtD
Aclidinium—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000197	0.0013	CcSEcCtD
Aclidinium—Headache—Clonazepam—epilepsy syndrome	0.000197	0.0013	CcSEcCtD
Aclidinium—Headache—Phenytoin—epilepsy syndrome	0.000196	0.00129	CcSEcCtD
Aclidinium—Headache—Oxcarbazepine—epilepsy syndrome	0.000195	0.00128	CcSEcCtD
Aclidinium—Dry mouth—Gabapentin—epilepsy syndrome	0.000194	0.00127	CcSEcCtD
Aclidinium—Vomiting—Carbamazepine—epilepsy syndrome	0.00019	0.00125	CcSEcCtD
Aclidinium—Infection—Gabapentin—epilepsy syndrome	0.000189	0.00124	CcSEcCtD
Aclidinium—BCHE—brain—epilepsy syndrome	0.000187	0.0122	CbGeAlD
Aclidinium—Headache—Carbamazepine—epilepsy syndrome	0.000187	0.00123	CcSEcCtD
Aclidinium—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000186	0.00122	CcSEcCtD
Aclidinium—Trospium—CYP2D6—epilepsy syndrome	0.000186	0.0294	CrCbGaD
Aclidinium—Tachycardia—Gabapentin—epilepsy syndrome	0.000185	0.00122	CcSEcCtD
Aclidinium—Vision blurred—Topiramate—epilepsy syndrome	0.000184	0.00121	CcSEcCtD
Aclidinium—Vomiting—Lamotrigine—epilepsy syndrome	0.000183	0.00121	CcSEcCtD
Aclidinium—Headache—Lamotrigine—epilepsy syndrome	0.000181	0.00119	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000179	0.00118	CcSEcCtD
Aclidinium—Cough—Topiramate—epilepsy syndrome	0.000171	0.00112	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000164	0.00108	CcSEcCtD
Aclidinium—Dry mouth—Topiramate—epilepsy syndrome	0.000163	0.00107	CcSEcCtD
Aclidinium—Infection—Topiramate—epilepsy syndrome	0.000159	0.00104	CcSEcCtD
Aclidinium—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000157	0.00103	CcSEcCtD
Aclidinium—Nervous system disorder—Topiramate—epilepsy syndrome	0.000157	0.00103	CcSEcCtD
Aclidinium—Tachycardia—Topiramate—epilepsy syndrome	0.000156	0.00103	CcSEcCtD
Aclidinium—Vomiting—Valproic Acid—epilepsy syndrome	0.000146	0.000958	CcSEcCtD
Aclidinium—Headache—Valproic Acid—epilepsy syndrome	0.000143	0.000944	CcSEcCtD
Aclidinium—Diarrhoea—Pregabalin—epilepsy syndrome	0.000142	0.000932	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000138	0.000907	CcSEcCtD
Aclidinium—Vomiting—Pregabalin—epilepsy syndrome	0.000132	0.000866	CcSEcCtD
Aclidinium—Diarrhoea—Gabapentin—epilepsy syndrome	0.00013	0.000854	CcSEcCtD
Aclidinium—Headache—Pregabalin—epilepsy syndrome	0.00013	0.000853	CcSEcCtD
Aclidinium—Vomiting—Gabapentin—epilepsy syndrome	0.000121	0.000794	CcSEcCtD
Aclidinium—Headache—Gabapentin—epilepsy syndrome	0.000119	0.000782	CcSEcCtD
Aclidinium—Diarrhoea—Topiramate—epilepsy syndrome	0.000109	0.000719	CcSEcCtD
Aclidinium—Vomiting—Topiramate—epilepsy syndrome	0.000102	0.000668	CcSEcCtD
Aclidinium—Headache—Topiramate—epilepsy syndrome	0.0001	0.000658	CcSEcCtD
Aclidinium—CHRM3—Metabolism—PLCB1—epilepsy syndrome	8.32e-06	6.86e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—TH—epilepsy syndrome	8.29e-06	6.83e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	8.29e-06	6.83e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	8.29e-06	6.83e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	8.29e-06	6.83e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	8.29e-06	6.83e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	8.29e-06	6.83e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	8.28e-06	6.83e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	8.26e-06	6.8e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	8.18e-06	6.74e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—AVP—epilepsy syndrome	8.17e-06	6.74e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	8.11e-06	6.68e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	8.08e-06	6.66e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HES1—epilepsy syndrome	8.07e-06	6.65e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GPX1—epilepsy syndrome	8.03e-06	6.62e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	8e-06	6.59e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—FYN—epilepsy syndrome	7.85e-06	6.47e-05	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.83e-06	6.45e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—H2AFX—epilepsy syndrome	7.82e-06	6.44e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MEF2C—epilepsy syndrome	7.81e-06	6.43e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	7.81e-06	6.43e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	7.81e-06	6.43e-05	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.8e-06	6.43e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	7.78e-06	6.41e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	7.78e-06	6.41e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HES1—epilepsy syndrome	7.73e-06	6.37e-05	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.73e-06	6.37e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	7.71e-06	6.35e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	7.71e-06	6.35e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	7.69e-06	6.34e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	7.67e-06	6.32e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	7.59e-06	6.26e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SST—epilepsy syndrome	7.59e-06	6.26e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	7.59e-06	6.26e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	7.59e-06	6.26e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SST—epilepsy syndrome	7.57e-06	6.24e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	7.57e-06	6.24e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	7.57e-06	6.24e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—YWHAZ—epilepsy syndrome	7.54e-06	6.22e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	7.53e-06	6.2e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—FYN—epilepsy syndrome	7.52e-06	6.19e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	7.5e-06	6.18e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SST—epilepsy syndrome	7.5e-06	6.18e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	7.5e-06	6.18e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	7.5e-06	6.18e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—H2AFX—epilepsy syndrome	7.49e-06	6.17e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MEF2C—epilepsy syndrome	7.48e-06	6.16e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NGF—epilepsy syndrome	7.46e-06	6.15e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	7.43e-06	6.12e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	7.43e-06	6.12e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	7.41e-06	6.1e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	7.4e-06	6.1e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	7.38e-06	6.08e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	7.34e-06	6.04e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	7.31e-06	6.02e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCR5—epilepsy syndrome	7.26e-06	5.98e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—YWHAZ—epilepsy syndrome	7.23e-06	5.95e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NGF—epilepsy syndrome	7.14e-06	5.89e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	7.14e-06	5.88e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	7.14e-06	5.88e-05	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	7.13e-06	5.87e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	7.12e-06	5.86e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	7.12e-06	5.86e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	7.11e-06	5.86e-05	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	7.11e-06	5.86e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HTR2A—epilepsy syndrome	7.1e-06	5.85e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	7.08e-06	5.84e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	7.08e-06	5.83e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	7.06e-06	5.81e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	7.05e-06	5.81e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	7.05e-06	5.81e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—AGT—epilepsy syndrome	7.04e-06	5.8e-05	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	7.04e-06	5.8e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	7.02e-06	5.78e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	7.01e-06	5.77e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	7.01e-06	5.77e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	6.99e-06	5.76e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	6.99e-06	5.76e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	6.99e-06	5.76e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	6.98e-06	5.75e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	6.96e-06	5.74e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCR5—epilepsy syndrome	6.95e-06	5.73e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—HMOX1—epilepsy syndrome	6.92e-06	5.7e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	6.92e-06	5.7e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	6.92e-06	5.7e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—APOE—epilepsy syndrome	6.9e-06	5.69e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	6.89e-06	5.68e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	6.84e-06	5.63e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CAT—epilepsy syndrome	6.83e-06	5.63e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	6.82e-06	5.62e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HTR2A—epilepsy syndrome	6.8e-06	5.6e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	6.75e-06	5.56e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TSC2—epilepsy syndrome	6.75e-06	5.56e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—AGT—epilepsy syndrome	6.74e-06	5.55e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ABCB1—epilepsy syndrome	6.64e-06	5.48e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	6.64e-06	5.47e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	6.62e-06	5.45e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—APOE—epilepsy syndrome	6.6e-06	5.44e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	6.55e-06	5.4e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	6.52e-06	5.37e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	6.49e-06	5.35e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	6.47e-06	5.33e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—KDR—epilepsy syndrome	6.47e-06	5.33e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TSC2—epilepsy syndrome	6.46e-06	5.32e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	6.45e-06	5.32e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—AGT—epilepsy syndrome	6.45e-06	5.32e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	6.43e-06	5.3e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	6.39e-06	5.27e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	6.36e-06	5.24e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	6.34e-06	5.23e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	6.33e-06	5.22e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—APOE—epilepsy syndrome	6.32e-06	5.21e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	6.31e-06	5.2e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	6.28e-06	5.18e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	6.25e-06	5.15e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PRKCB—epilepsy syndrome	6.23e-06	5.13e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL6ST—epilepsy syndrome	6.2e-06	5.11e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—KDR—epilepsy syndrome	6.19e-06	5.1e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GPX1—epilepsy syndrome	6.18e-06	5.09e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	6.02e-06	4.96e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	6e-06	4.94e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PRKCB—epilepsy syndrome	5.96e-06	4.91e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	5.96e-06	4.91e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	5.94e-06	4.9e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	5.94e-06	4.89e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	5.94e-06	4.89e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL6ST—epilepsy syndrome	5.94e-06	4.89e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—POMC—epilepsy syndrome	5.93e-06	4.89e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	5.93e-06	4.88e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	5.88e-06	4.85e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	5.87e-06	4.84e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	5.76e-06	4.74e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	5.74e-06	4.73e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	5.68e-06	4.68e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—POMC—epilepsy syndrome	5.67e-06	4.67e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCL2—epilepsy syndrome	5.55e-06	4.57e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	5.44e-06	4.48e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—POMC—epilepsy syndrome	5.43e-06	4.48e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	5.42e-06	4.47e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—AGT—epilepsy syndrome	5.42e-06	4.46e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ALB—epilepsy syndrome	5.41e-06	4.45e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	5.37e-06	4.43e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL2—epilepsy syndrome	5.31e-06	4.38e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—APOE—epilepsy syndrome	5.31e-06	4.37e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	5.29e-06	4.36e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	5.28e-06	4.35e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	5.27e-06	4.35e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	5.26e-06	4.34e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	5.26e-06	4.33e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	5.25e-06	4.32e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	5.22e-06	4.3e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	5.21e-06	4.29e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	5.2e-06	4.28e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.09e-06	4.19e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	5.07e-06	4.18e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	5.03e-06	4.15e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	5.02e-06	4.14e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—FGF2—epilepsy syndrome	5.02e-06	4.13e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	5.01e-06	4.13e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	4.97e-06	4.09e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	4.89e-06	4.03e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	4.88e-06	4.02e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	4.83e-06	3.98e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—FGF2—epilepsy syndrome	4.8e-06	3.96e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	4.79e-06	3.95e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	4.77e-06	3.93e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PTGS2—epilepsy syndrome	4.73e-06	3.9e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	4.73e-06	3.9e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—RELA—epilepsy syndrome	4.66e-06	3.84e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MTOR—epilepsy syndrome	4.57e-06	3.76e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—POMC—epilepsy syndrome	4.56e-06	3.76e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	4.55e-06	3.75e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	4.54e-06	3.74e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	4.53e-06	3.74e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	4.53e-06	3.73e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	4.49e-06	3.7e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	4.49e-06	3.7e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—RELA—epilepsy syndrome	4.46e-06	3.67e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	4.45e-06	3.67e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	4.44e-06	3.66e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	4.39e-06	3.62e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MTOR—epilepsy syndrome	4.37e-06	3.6e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	4.36e-06	3.59e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	4.35e-06	3.58e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	4.31e-06	3.55e-05	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—AKT1—epilepsy syndrome	4.24e-06	3.49e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CASP3—epilepsy syndrome	4.2e-06	3.46e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	4.2e-06	3.46e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	4.18e-06	3.45e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	4.18e-06	3.45e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	4.17e-06	3.43e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ALB—epilepsy syndrome	4.16e-06	3.43e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	4.14e-06	3.42e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	4.13e-06	3.4e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—JUN—epilepsy syndrome	4.08e-06	3.36e-05	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	4.06e-06	3.34e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	4.02e-06	3.31e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	3.97e-06	3.27e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	3.91e-06	3.22e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	3.85e-06	3.17e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	3.82e-06	3.15e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	3.81e-06	3.14e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	3.8e-06	3.13e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	3.78e-06	3.11e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	3.74e-06	3.08e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	3.73e-06	3.07e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	3.69e-06	3.04e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	3.69e-06	3.04e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	3.66e-06	3.02e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PTGS2—epilepsy syndrome	3.64e-06	3e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	3.56e-06	2.94e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	3.5e-06	2.89e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	3.41e-06	2.81e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	3.38e-06	2.79e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	3.37e-06	2.78e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	3.34e-06	2.75e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	3.14e-06	2.59e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	3.13e-06	2.58e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	3.1e-06	2.55e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	3.08e-06	2.54e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	3.07e-06	2.53e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	3.04e-06	2.5e-05	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.86e-06	2.36e-05	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.85e-06	2.35e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.83e-06	2.33e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	2.82e-06	2.33e-05	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.82e-06	2.32e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	2.8e-06	2.3e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	2.75e-06	2.27e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	2.74e-06	2.26e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	2.72e-06	2.24e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.68e-06	2.21e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	2.67e-06	2.2e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	2.64e-06	2.18e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	2.6e-06	2.14e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	2.59e-06	2.13e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	2.56e-06	2.11e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	2.47e-06	2.03e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	2.46e-06	2.03e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	2.44e-06	2.01e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.4e-06	1.98e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	2.4e-06	1.97e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—AKT1—epilepsy syndrome	2.38e-06	1.96e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	2.37e-06	1.95e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	2.27e-06	1.87e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	2.18e-06	1.79e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.83e-06	1.51e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.53e-06	1.26e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.53e-06	1.26e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.51e-06	1.25e-05	CbGpPWpGaD
